Search

Christopher Upton

Examiner (ID: 5454, Phone: (571)272-1169 , Office: P/1778 )

Most Active Art Unit
1778
Art Unit(s)
1724, 1778, 1306, 1797, 1776, 1308
Total Applications
3146
Issued Applications
2580
Pending Applications
123
Abandoned Applications
451

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17533613 [patent_doc_number] => 20220112222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY [patent_app_type] => utility [patent_app_number] => 17/532109 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532109 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532109
Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography Nov 21, 2021 Issued
Array ( [id] => 17473948 [patent_doc_number] => 20220081452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY [patent_app_type] => utility [patent_app_number] => 17/532083 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532083 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532083
Method of preparing zirconium-89 oxine complex Nov 21, 2021 Issued
Array ( [id] => 17426939 [patent_doc_number] => 20220054647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/518794 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518794 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/518794
SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF Nov 3, 2021 Abandoned
Array ( [id] => 17412821 [patent_doc_number] => 20220047725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING [patent_app_type] => utility [patent_app_number] => 17/451536 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 359 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17451536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/451536
Chemiluminescent probes for diagnostics and in vivo imaging Oct 19, 2021 Issued
Array ( [id] => 17369844 [patent_doc_number] => 20220024896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => TAU PET IMAGING LIGANDS [patent_app_type] => utility [patent_app_number] => 17/450212 [patent_app_country] => US [patent_app_date] => 2021-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14911 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450212 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/450212
Tau PET imaging ligands Oct 6, 2021 Issued
Array ( [id] => 17519401 [patent_doc_number] => 20220105249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => X-RAY AND MRI VISIBLE SHAPE MEMORY POLYMER BIOPSY SEALING DEVICE [patent_app_type] => utility [patent_app_number] => 17/495009 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11751 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495009 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/495009
X-RAY AND MRI VISIBLE SHAPE MEMORY POLYMER BIOPSY SEALING DEVICE Oct 5, 2021 Pending
Array ( [id] => 17755578 [patent_doc_number] => 11395857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy [patent_app_type] => utility [patent_app_number] => 17/494367 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 18302 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/494367
Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy Oct 4, 2021 Issued
Array ( [id] => 18340435 [patent_doc_number] => 20230132384 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2023-04-27 [patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE [patent_app_type] => utility [patent_app_number] => 17/492260 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22181 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492260 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/492260
Compositions and methods for assessing eye vasculature Sep 30, 2021 Issued
Array ( [id] => 18340435 [patent_doc_number] => 20230132384 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2023-04-27 [patent_title] => COMPOSITIONS AND METHODS FOR ASSESSING EYE VASCULATURE [patent_app_type] => utility [patent_app_number] => 17/492260 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22181 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492260 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/492260
Compositions and methods for assessing eye vasculature Sep 30, 2021 Issued
Array ( [id] => 19563570 [patent_doc_number] => 12138321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => Half-curcuminoids as amyloid-b PET imaging agents [patent_app_type] => utility [patent_app_number] => 17/448463 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 17409 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 322 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/448463
Half-curcuminoids as amyloid-b PET imaging agents Sep 21, 2021 Issued
Array ( [id] => 19472632 [patent_doc_number] => 12102695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Half-curcuminoids as amyloid-beta pet imaging agents [patent_app_type] => utility [patent_app_number] => 17/480924 [patent_app_country] => US [patent_app_date] => 2021-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 17409 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 359 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/480924
Half-curcuminoids as amyloid-beta pet imaging agents Sep 20, 2021 Issued
Array ( [id] => 18784872 [patent_doc_number] => 20230372554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => SIZE CONTROLLED RADIOLABELLED PARTICLES [patent_app_type] => utility [patent_app_number] => 18/044678 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044678 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044678
SIZE CONTROLLED RADIOLABELLED PARTICLES Sep 14, 2021 Pending
Array ( [id] => 18707697 [patent_doc_number] => 20230330280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/044665 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8904 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044665
PREPARATIONS OF RADIUM-224 AND PROGENIES FOR USE IN RADIONUCLIDE THERAPY IN COMBINATION WITH DNA REPAIR INHIBITORS Sep 14, 2021 Pending
Array ( [id] => 17519065 [patent_doc_number] => 20220104913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => MULTI-MODE IMAGING MARKERS [patent_app_type] => utility [patent_app_number] => 17/473820 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15427 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17473820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/473820
Multi-mode imaging markers Sep 12, 2021 Issued
Array ( [id] => 17443510 [patent_doc_number] => 20220064015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 [patent_app_type] => utility [patent_app_number] => 17/466443 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466443 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/466443
Purification process for the preparation of non-carrier added copper-64 Sep 2, 2021 Issued
Array ( [id] => 17451915 [patent_doc_number] => 11266752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-08 [patent_title] => Methods of imaging and delivering therapeutic agents [patent_app_type] => utility [patent_app_number] => 17/403429 [patent_app_country] => US [patent_app_date] => 2021-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 28 [patent_no_of_words] => 19893 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403429 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/403429
Methods of imaging and delivering therapeutic agents Aug 15, 2021 Issued
Array ( [id] => 19195316 [patent_doc_number] => 11992534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Methods for treating and diagnosing blinding eye diseases [patent_app_type] => utility [patent_app_number] => 17/392453 [patent_app_country] => US [patent_app_date] => 2021-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 30797 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/392453
Methods for treating and diagnosing blinding eye diseases Aug 2, 2021 Issued
Array ( [id] => 17702956 [patent_doc_number] => 20220202962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => NITROXIDE CONTAINING AMYLOID BINDING AGENTS FOR IMAGING AND THERAPEUTIC USES [patent_app_type] => utility [patent_app_number] => 17/389674 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17389674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/389674
Nitroxide containing amyloid binding agents for imaging and therapeutic uses Jul 29, 2021 Issued
Array ( [id] => 17227224 [patent_doc_number] => 20210353780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => ASCORBATE FORMULATIONS AND METHODS OF USE AS CONTRAST AGENTS [patent_app_type] => utility [patent_app_number] => 17/443863 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443863 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/443863
Ascorbate formulations and methods of use as contrast agents Jul 27, 2021 Issued
Array ( [id] => 17297974 [patent_doc_number] => 20210393813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => MULTINUCLEAR COMPLEXES AND THEIR PREPARATION [patent_app_type] => utility [patent_app_number] => 17/379011 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379011 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/379011
Multinuclear complexes and their preparation Jul 18, 2021 Issued
Menu